Silencing Myostatin Using In Vivo Self‐Assembled siRNA Protects Against Cancer‐ and Dexamethasone‐Induced Muscle Atrophy
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202502186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Xin Yin und 14 weiteren Autor:innen. Beteiligte Einrichtung: PKU-HKUST ShenZhen-HongKong Institution, Shenzhen, Guangdong, 518057, China. Hauptthemen laut MEDLINE: Myostatin, Muscular Atrophy, RNA, Small Interfering, Dexamethasone. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Starry Night Science Fund of Zhejiang University Shanghai Institute for Advanced Study, CAMS Innovation Fund for Medical Sciences.
Abstract (Originalsprache)
Maintaining skeletal muscle mass is crucial for health, as muscle atrophy caused by drugs, cancer, or aging poses serious risks. However, there are few effective pharmacological interventions targeting muscle atrophy, highlighting the need for new therapeutic strategies. In this study, in vivo self‐assembled siRNA is designed to silence myostatin (MSTN), a key regulator of muscle growth and atrophy, aiming to prevent muscle atrophy. Using synthetic constructs and the host liver as a scaffold, the assembly of MSTN‐siRNA is guided into muscle‐specific peptide MSP‐tagged small extracellular vesicles (sEVs). These MSP‐tagged sEVs selectively deliver MSTN‐siRNA to muscle tissue. Treatment significantly reduces MSTN protein levels in skeletal muscle, promotes muscle mass gain in healthy mice, and protectes skeletal muscles from atrophy in cancer‐ and dexamethasone‐induced muscle atrophy models. Notably, the sEV‐encapsulated MSTN‐siRNA is produced in a nontoxic, nonimmunogenic, and biocompatible manner. This study offers a promising therapeutic approach for muscle atrophy, addressing a key gap in current treatment options and potentially improving outcomes for patients with muscle‐wasting conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- PKU-HKUST ShenZhen-HongKong Institution, Shenzhen, Guangdong, 518057, China.
- Pingshan Translational Medicine Center, Shenzhen Bay Laboratory, Shenzhen, Guangdong, 518118, China.
- Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, Chinese Academy of Medical Sciences Research Unit of Extracellular RNA, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering R…
- The Research Center of Military Exercise Science, The Army Engineering University of PLA, Nanjing, Jiangsu, 210007, China.
- Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Key Laborat…
- State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, 518055, China.
ORCID-Profile: Xi Chen
Förderung
- National Natural Science Foundation of China
- Starry Night Science Fund of Zhejiang University Shanghai Institute for Advanced Study
- CAMS Innovation Fund for Medical Sciences
- Shenzhen Science and Technology Program
- Natural Science Foundation of Jiangsu Province
- Army Engineering University of PLA
- Shenzhen Science and Technology Innovation Program
Zitieren
APA
Yin, X., Anwar, A., Chen, J., Sun, Q., Zhou, L., Tang, J., Guo, J., Yan, L., Chen, Y., Yin, F., Zhang, C. Y., Li, Z., Ma, J., Sheng, L., & Chen, X. (2026). Silencing Myostatin Using In Vivo Self‐Assembled siRNA Protects Against Cancer‐ and Dexamethasone‐Induced Muscle Atrophy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202502186
Vancouver
Yin X, Anwar A, Chen J, Sun Q, Zhou L, Tang J, et al. Silencing Myostatin Using In Vivo Self‐Assembled siRNA Protects Against Cancer‐ and Dexamethasone‐Induced Muscle Atrophy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202502186
BibTeX
@article{Yin2026,
author = {Yin, Xin and Anwar, Azhar and Chen, Jiehao and Sun, Qinghao and Zhou, Likun and Tang, Jie and Guo, Jingwei and Yan, Linbo and Chen, Yongci and Yin, Feng and Zhang, Chen-Yu and Li, Zigang and Ma, Jizheng and Sheng, Liyuan and Chen, Xi},
title = {Silencing Myostatin Using In Vivo Self‐Assembled siRNA Protects Against Cancer‐ and Dexamethasone‐Induced Muscle Atrophy},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202502186}
}
EUVIMED